Taxanes Versus Pemetrexed After Osimertinib Resistance in EGFR-Mutated NSCLC: A Retrospective Cohort with Two-Model In Vitro Validation
Ning Yang,1,* Ning Wan,2,3,* Ya Guo,2,3 Lijuan Xiong,4 Xiting Chen,4 Dou Du,4 Bo Xie,1,4 Juan Zhou1,4 1Department of Oncology, General Hospital of Southern Theater Command, Guangzhou, People’s Republic of China; 2Department of Clinical Pharmacy, General Hospital of Southern Theater C...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2026-01-01
|
| Edice: | Cancer Management and Research |
| Témata: | |
| On-line přístup: | https://www.dovepress.com/taxanes-versus-pemetrexed-after-osimertinib-resistance-in-egfr-mutated-peer-reviewed-fulltext-article-CMAR |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|